Northernchem Inc., headquartered in Niagara Falls, Ontario, is a Canadian high-tech chemical and pharmaceutical company providing quality products and research & development. Our business includes (1) New drug R&D (2) Generic drugs (3) Pharmaceutical intermediates (4) Natural & health products (5) 3D printing of medical models and parts.
We employ top scientists, the majority of whom hold a Ph.D. and have Postdoctoral experience from well recognized universities such as: Harvard University, University of California, U.S. National Institutes of Health, Queen’s University, University of Toronto, McGill University, University of Waterloo, McMaster University, Chinese Academy of Sciences, Tsinghua University, and Peking University. In addition to their world-class education, our scientists have many academic papers published in peer-reviewed journals, such as Nature, Cell, Cancer Research, JACS, Angewandte Chemie, JMC, JOC, and Analytical Chemistry. By employing exceptional individuals of various backgrounds, we are able to gain well-rounded insight to stay competitive within our field.
The Research and Development department at Northernchem Inc. is working on contributing to the cures of several debilitating conditions through pharmaceutical and chemical research. Our current R&D is focused on neurological drugs, anti-cancer drugs, stem cells and accelerator, new technologies for generic drugs, and nano-formulation development. We have achieved substantive results and our new discoveries are on a path that leads to promising new type of drugs. Annually, we have accomplished approximately ten significant breakthroughs in new technologies for generic drugs. More than three hundred of new pharmaceutical intermediates are being designed and synthesized in a year. At present, we published 12 peer-reviewed papers, owned and applied 7 patents.



Comments
Post a Comment